Skip to main content
Michael Ober, MD, Ophthalmology, Southfield, MI

Michael D Ober MD

Retinal Disease


Vitreoretinal Surgeon at Retina Consultants of Michigan Associate Professor of Ophthalmology Oakland University William Beaumont School of Medicine Teaching Faculty Henry Ford Hospital Chief of Staff, Straith Hospital for Special Surgery

Join to View Full Profile
  • 29201 Telegraph RdSuite #606Southfield, MI 48034

  • Phone+1 248-356-8610

  • Fax+1 248-356-6473

Dr. Ober is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • New York Presbyterian Hospital (Columbia Campus)
    New York Presbyterian Hospital (Columbia Campus)Fellowship, Surgical Retina and Vitreous, 2003 - 2005
  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Ophthalmology, 1999 - 2003
  • Corewell Health East Beaumont (Royal Oak)
    Corewell Health East Beaumont (Royal Oak)Internship, Transitional Year, 1999 - 2000
  • Wayne State University School of Medicine
    Wayne State University School of MedicineClass of 1999, MD
  • Cornell University
    Cornell UniversityBA, Chemistry, 1991 - 1995

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2000 - Present
  • MI State Medical License
    MI State Medical License 2005 - 2027
  • CA State Medical License
    CA State Medical License 2003 - 2025
  • Ophthalmology
    American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

  • Fellow (FACS) American College of Surgeons
  • Fellow (FAAO) American Academy of Ophthalmology

Publications & Presentations

PubMed

Press Mentions

  • Diagnosis and Management of Pathologic Myopia
    Diagnosis and Management of Pathologic MyopiaNovember 1st, 2019
  • SUBSPECIALTY NEWS: Results for Combination Therapy for DME, FDA Asks for Information on Xipere, Depo-Medrol Retinal Toxicity, and More
    SUBSPECIALTY NEWS: Results for Combination Therapy for DME, FDA Asks for Information on Xipere, Depo-Medrol Retinal Toxicity, and MoreOctober 1st, 2019

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: